AU1130300A - Oral glutamine in the prevention of neonatal necrotizing enterocolitis and othergastrointestinal mucosal damage - Google Patents
Oral glutamine in the prevention of neonatal necrotizing enterocolitis and othergastrointestinal mucosal damageInfo
- Publication number
- AU1130300A AU1130300A AU11303/00A AU1130300A AU1130300A AU 1130300 A AU1130300 A AU 1130300A AU 11303/00 A AU11303/00 A AU 11303/00A AU 1130300 A AU1130300 A AU 1130300A AU 1130300 A AU1130300 A AU 1130300A
- Authority
- AU
- Australia
- Prior art keywords
- othergastrointestinal
- prevention
- necrotizing enterocolitis
- mucosal damage
- neonatal necrotizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010051606 Necrotising colitis Diseases 0.000 title 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 title 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1999/024737 WO2001030340A1 (en) | 1997-03-17 | 1999-10-22 | Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1130300A true AU1130300A (en) | 2001-05-08 |
Family
ID=22273882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11303/00A Abandoned AU1130300A (en) | 1999-10-22 | 1999-10-22 | Oral glutamine in the prevention of neonatal necrotizing enterocolitis and othergastrointestinal mucosal damage |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1244439A4 (en) |
| JP (1) | JP2003521481A (en) |
| AU (1) | AU1130300A (en) |
| CA (1) | CA2388724A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007004613A1 (en) * | 2005-07-01 | 2009-01-29 | 味の素株式会社 | Inflammatory bowel disease therapeutic agent and TNF-α production inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0172193B1 (en) * | 1991-10-07 | 1999-02-01 | 오오쓰까 아끼히꼬 | Enteral preparations for cancer treatment |
-
1999
- 1999-10-22 AU AU11303/00A patent/AU1130300A/en not_active Abandoned
- 1999-10-22 JP JP2001532760A patent/JP2003521481A/en active Pending
- 1999-10-22 CA CA002388724A patent/CA2388724A1/en not_active Abandoned
- 1999-10-22 EP EP99955126A patent/EP1244439A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2388724A1 (en) | 2001-05-03 |
| JP2003521481A (en) | 2003-07-15 |
| EP1244439A4 (en) | 2003-05-28 |
| EP1244439A1 (en) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2108501A (en) | Mpeg re-multiplexer having multiple inputs and multiple outputs | |
| AU2002219472A1 (en) | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens | |
| AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
| IL144325A0 (en) | Compositions and methods for mucosal delivery | |
| AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
| AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU4671601A (en) | Medical combinations comprising formoterol and budesonide | |
| AU1812001A (en) | Cotton transcription factors and their uses | |
| HUP0102781A3 (en) | Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies | |
| AU3099997A (en) | The use of tcet in the prophylaxis and treatment of allergies | |
| GB2367103B (en) | Connector and method of use of the connector | |
| AU2002243363A1 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
| AU2841801A (en) | Triazolotriazinones and the use thereof | |
| EP1226836A4 (en) | Suction connector and suction catheter using the connector | |
| AU4853801A (en) | Medical combination comprising salmeterol and budesonide | |
| AU4854101A (en) | Medical combinations comprising formoterol and mometasone | |
| AU2002214263A1 (en) | Mucosal immunomodulator and use thereof | |
| AU2002366809A1 (en) | Syn3 compositions and methods | |
| AU1130300A (en) | Oral glutamine in the prevention of neonatal necrotizing enterocolitis and othergastrointestinal mucosal damage | |
| AU6710900A (en) | Field emitters and devices | |
| AU7130600A (en) | Functionally enhanced protective shrink-wrap coverings and methods for their manufacture and use | |
| AU7907400A (en) | Novel combination of loteprednol and beta2-adrenoceptor agonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |